Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes? (Q39012899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

review article

1 reference

title

Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

author name string

J Surendar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

K Indulekha

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

A Hoerauf

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

1 reference

15 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

The pathologic continuum of diabetic vascular disease

27 March 2020

cites work

1 reference

Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design

21 January 2018

1 reference

Diabetes and cancer: a consensus report.

21 January 2018

1 reference

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future

21 January 2018

1 reference

Targeting inflammation in the treatment of type 2 diabetes: time to start

21 January 2018

1 reference

Anti-inflammatory therapy in type 1 diabetes

21 January 2018

1 reference

Diversity and dialogue in immunity to helminths.

21 January 2018

1 reference

Lymphatic filariasis: new insights and prospects for control

21 January 2018

1 reference

Immunity to helminths: resistance, regulation, and susceptibility to gastrointestinal nematodes

21 January 2018

1 reference

A case of hookworm infestation in a precolumbian American

21 January 2018

1 reference

Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies?

21 January 2018

1 reference

A missing link in the hygiene hypothesis?

21 January 2018

1 reference

Helminths as governors of immune-mediated inflammation

21 January 2018

1 reference

Filariasis in Africa—treatment challenges and prospects

21 January 2018

1 reference

Lymphatic filariasis and onchocerciasis

21 January 2018

1 reference

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

21 January 2018

1 reference

Helminth-Tuberculosis Co-infection: An Immunologic Perspective

21 January 2018

1 reference

Helpful or a hindrance: co-infections with helminths during malaria

21 January 2018

1 reference

Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study

21 January 2018

1 reference

Parasitic helminth infections and the control of human allergic and autoimmune disorders

21 January 2018

1 reference

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus

21 January 2018

1 reference

Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome

21 January 2018

1 reference

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

Genetic linkage and association studies of Type I diabetes: challenges and rewards

21 January 2018

1 reference

Immunologic and genetic factors in type 1 diabetes

21 January 2018

1 reference

The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes

21 January 2018

1 reference

Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population

21 January 2018

1 reference

Hay fever, hygiene, and household size

21 January 2018

1 reference

Helminths in the hygiene hypothesis: sooner or later?

21 January 2018

1 reference

Parasites and the hygiene hypothesis: regulating the immune system?

21 January 2018

1 reference

A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland

21 January 2018

1 reference

The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland

21 January 2018

1 reference

Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications

21 January 2018

1 reference

Viral infections in type 1 diabetes mellitus--why the β cells?

21 January 2018

1 reference

Virus infections in type 1 diabetes

21 January 2018

1 reference

Infection and type 1 diabetes mellitus - a two edged sword?

21 January 2018

1 reference

Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes.

21 January 2018

1 reference

Immune cell crosstalk in type 1 diabetes

21 January 2018

1 reference

Decreased Prevalence of Lymphatic Filariasis Among Subjects with Type-1 Diabetes

21 January 2018

1 reference

Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes

21 January 2018

1 reference

Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression.

21 January 2018

1 reference

Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

21 January 2018

1 reference

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

21 January 2018

1 reference

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

CD4 CD25 regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

21 January 2018

1 reference

Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4 CD25 Foxp3 regulatory T cells.

21 January 2018

1 reference

Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice

21 January 2018

1 reference

Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems

21 January 2018

1 reference

Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice

21 January 2018

1 reference

The S. mansoni glycoprotein ω-1 induces Foxp3 expression in NOD mouse CD4⁺ T cells

21 January 2018

1 reference

Litomosoides sigmodontis in mice: reappraisal of an old model for filarial research

21 January 2018

1 reference

Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3 regulatory T cells

21 January 2018

1 reference

Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice

21 January 2018

1 reference

Helminth Protection against Autoimmune Diabetes in Nonobese Diabetic Mice Is Independent of a Type 2 Immune Shift and Requires TGF-β

21 January 2018

1 reference

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

21 January 2018

1 reference

Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs

21 January 2018

1 reference

Combination of worm antigen and proinsulin prevents type 1 diabetes in NOD mice after the onset of insulitis.

21 January 2018

1 reference

Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection

21 January 2018

1 reference

Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms

21 January 2018

1 reference

Heligmosomoides polygyrus infection reduces severity of type 1 diabetes induced by multiple low-dose streptozotocin in mice via STAT6- and IL-10-independent mechanisms

21 January 2018

1 reference

Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes

21 January 2018

1 reference

Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes.

21 January 2018

1 reference

Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages

21 January 2018

1 reference

Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.

21 January 2018

1 reference

Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse

21 January 2018

1 reference

A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice

21 January 2018

1 reference

Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy

21 January 2018

1 reference

Leptin therapy in insulin-deficient type I diabetes

21 January 2018

1 reference

Adipose tissue, hormones, and treatment of type 1 diabetes.

21 January 2018

1 reference

Reversal of type 1 diabetes in mice by brown adipose tissue transplant.

21 January 2018

1 reference

Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.

21 January 2018

1 reference

Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies

21 January 2018

1 reference

Hepatic steatosis in type 1 diabetes

21 January 2018

1 reference

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis.

21 January 2018

1 reference

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

21 January 2018

1 reference

Inflammation and insulin resistance

21 January 2018

1 reference

Inflammatory Mechanisms in Obesity

21 January 2018

1 reference

Immune regulation of metabolic homeostasis in health and disease.

21 January 2018

1 reference

Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis

21 January 2018

1 reference

Macrophages, inflammation, and insulin resistance

21 January 2018

1 reference

The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance

21 January 2018

1 reference

The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance.

21 January 2018

1 reference

Adaptive immunity in obesity and insulin resistance

21 January 2018

1 reference

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China

21 January 2018

1 reference

Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83)

21 January 2018

1 reference

Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? Evidence from Australian Aboriginal adults.

21 January 2018

1 reference

Infection with Soil-Transmitted Helminths Is Associated with Increased Insulin Sensitivity

21 January 2018

1 reference

Helminth infections, type-2 immune response, and metabolic syndrome

21 January 2018

1 reference

Helminth infections and type 2 diabetes: a cluster-randomized placebo controlled SUGARSPIN trial in Nangapanda, Flores, Indonesia

21 January 2018

1 reference

A Mouse Model of Diet-Induced Obesity and Insulin Resistance

21 January 2018

1 reference

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

21 January 2018

1 reference

Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity

21 January 2018

1 reference

Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice

21 January 2018

1 reference

Filarial Infection or Antigen Administration Improves Glucose Tolerance in Diet-Induced Obese Mice.

21 January 2018

1 reference

Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways

21 January 2018

1 reference

The helminth T2 RNase ω1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism.

21 January 2018

1 reference

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

21 January 2018

1 reference

Immune regulation during helminth infections

21 January 2018

1 reference

Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis

21 January 2018

1 reference

Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.

21 January 2018

1 reference

Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

21 January 2018

1 reference

Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.

21 January 2018

1 reference

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

21 January 2018

1 reference

B-1a lymphocytes attenuate insulin resistance

21 January 2018

1 reference

Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis.

21 January 2018

1 reference

Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

21 January 2018

1 reference

Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis

21 January 2018

1 reference

Activated type 2 innate lymphoid cells regulate beige fat biogenesis

21 January 2018

1 reference

Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity

21 January 2018

1 reference

Dietary weight loss and exercise effects on insulin resistance in postmenopausal women

21 January 2018

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia

21 January 2018

1 reference

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

Gut microbiota and obesity.

21 January 2018

1 reference

Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes

21 January 2018

1 reference

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

Gut Microbiota Orchestrates Energy Homeostasis during Cold.

21 January 2018

1 reference

Helminth colonization is associated with increased diversity of the gut microbiota.

21 January 2018

1 reference

Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus

21 January 2018

1 reference

Interactions between multiple helminths and the gut microbiota in wild rodents

21 January 2018

1 reference

The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation.

21 January 2018

1 reference

Helminth infection promotes colonization resistance via type 2 immunity.

21 January 2018

1 reference

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

21 January 2018

1 reference

Direct control of hepatic glucose production by interleukin-13 in mice.

21 January 2018

1 reference

Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice

21 January 2018

1 reference

Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection

21 January 2018

1 reference

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response

21 January 2018

1 reference

Chronic Opisthorchis felineus infection attenuates atherosclerosis--an autopsy study

21 January 2018

1 reference

An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol

21 January 2018

1 reference

Effects of Schistosoma mansoni worms and eggs on circulating cholesterol and liver lipids in mice.

21 January 2018

1 reference

Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities

21 January 2018

1 reference

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

21 January 2018

1 reference

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

Type 2 diabetes-a matter of beta-cell life and death?

21 January 2018

1 reference

Alternatively activated macrophages in types 1 and 2 diabetes

21 January 2018

1 reference

In CD4 T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

21 January 2018

1 reference

The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

Increased number of islet-associated macrophages in type 2 diabetes.

21 January 2018

1 reference

Islet inflammation in type 2 diabetes: from metabolic stress to therapy.

21 January 2018

1 reference

IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB.

21 January 2018

1 reference

Macrophages, cytokines and beta-cell death in Type 2 diabetes

21 January 2018

1 reference

New drugs for rheumatoid arthritis

21 January 2018

1 reference

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

21 January 2018

1 reference

One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus.

21 January 2018

1 reference

Helminth mediated modulation of Type 1 diabetes (T1D).

21 January 2018

1 reference

Helminth infection and type 1 diabetes

21 January 2018

1 reference

IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity.

21 January 2018

1 reference

Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes

21 January 2018

1 reference

Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage

21 January 2018

1 reference

Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis

21 January 2018

1 reference

Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes

21 January 2018

1 reference

Chronic filarial infection provides protection against bacterial sepsis by functionally reprogramming macrophages

21 January 2018

1 reference

Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour?

21 January 2018

1 reference

Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62.

21 January 2018

1 reference

The Schistosoma mansoni T2 ribonuclease omega-1 modulates inflammasome-dependent IL-1β secretion in macrophages

21 January 2018

1 reference

Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses

21 January 2018

1 reference

Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PIM.12401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27862000 AND SRC:MED&resulttype=core&format=json

27 March 2020

1 reference